Clinical Trial: Real world observational registry study evaluting efficacy and safety of Solriamfetol, a wake-promoting agent, for the treatment of OSA patients with EDS (China)

Posted On: 2026-09-11

China, Sept. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Real world observational registry study evaluting efficacy and safety of Solriamfetol, a wake-promoting agent, for the treatment of OSA patients with EDS'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132209

Registration Time: 2026/09/10

Type: Observational study

Primary Sponsor: Peking Union Medical College Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=342339

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Real world observational registry study evaluting efficacy and safety of Solriamfetol, a wake-promoting agent, for the treatment of OSA patients with EDS (China)